Search

Why does Germany have such an under developed venture capital market? Science|Business speaks to Rolf Dienst, one of the country’s most prominent VCs.

A long-time Cinderella, the biotechnology sector in Italy now has a turnover of more than 10 billion euros. It may now be poised to make its mark internationally.

As part of its recent reorganization, HP is taking Open Innovation to the next level by seeking proposals to fund hot new technologies.

In 2007, the UK’s largest retail chemists chain set up a dedicated centre at Swansea University to promote open innovation. One year on, the first product is about to hit the market.

Finnish researcher Jyrki Ali-Yrkkö, of the Helsinki School of Economics, has shown it is possible to increase the R&D activities of companies through public funding.

Record venture capital and heated deal environment propelled biotechnology industry forward in 2007, says Ernst & Young’s biotech report for last year.

The UK Technology Strategy Board has published its three-year strategic plan and outlined how it will promote and invest in technology-driven innovation.

The European Commission has launched a public consultation to inform a move to modernise and simplify the legislation on medical devices.

Europe’s politicians claim they are inching towards the Community Patent. But translation is still an issue and a single litigation area remains a distant hope.

Basic science remains of central importance, John Denham, UK Secretary of State for Innovation reassured the UK’s leading scientists in a speech last month.